Appointment of Mr Steven Lydeamore as Chef Executive Officer
Filed with ASX · · 3 pages · English
Earlier from Immuron
- Immuron Q3 Global Sales up 216% YoY
- Half Yearly Report and Accounts
- Response to ASX Query
- Immuron Receives European Patent on Drug to Treat Diarrhea
- US DoD Travelan Clinical Update
Later from Immuron
- US DoD Uniformed Services University Clinical Update
- US DoD NMRC files IND application with FDA
- European Patent Notification on Drug Composition for CDI
- North American Travelan Sales up 494%, Global sales up 431%
- Immuron Update on IMM-124E SARS-CoV-2 Research
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron